Evidence map›Paper›PMID 40757058›Full record

ArticleTherapeutic advances in rare disease

Updated demographics categories to capture the true diversity of an international registry of rare disease patients.

Nicole Kressin, Michael E Shy, Tara Jones, Nidia Villalpando, Gita Ramdharry

Abstract read
In one paragraph

Article in Therapeutic advances in rare disease. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Nicole KressinUniversity of Iowa, 200 Hawkins Dr., Iowa City 52242-1009, IA, USA.ORCID https://orcid.org/0009-0008-7070-8131
Michael E ShyUniversity of Iowa, Iowa City, IA, USA.
Tara JonesCedars-Sinai Medical Center, Los Angeles, CA, USA.
Nidia VillalpandoUniversity of Iowa, Iowa City, IA, USA.
Gita RamdharryUniversity College London, London, UK.ORCID https://orcid.org/0000-0001-9344-0301

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: NIH requires NIH-funded studies to use historical race and ethnicity categories-originally put forth by the Office of Management and Budget in 1997-for demographics collection. These historical categories were only designed for use within the United States (US). We speculated on the adequacy of these categories in capturing the true diversity of participants enrolled in the Inherited Neuropathy Consortium (INC), and their applicability for an international, broader rare disease population. Objectives: To determine the feasibility and outcomes of using updated categories for rare disease patients that can be collapsed into the required historical categories. Design: This was achieved by expanding on existing government categories from countries with INC sites to create categories that reached 100% consensus of the research team. Quantitative cross-sectional analysis was performed in two cohorts. Methods: Common government census categories among the US, the United Kingdom, Italy, and Australia were used to generate updated demographic categories capturing racial, ethnic, sex, and gender identities. We piloted the updated categories at three INC sites with participants who were participating in the INC. We made a minor update and sent the survey to anyone who had joined the Rare Disease Clinical Research Network's contact registry. Results: Both the pilot study and the contact registry saw an increase in diversity with the updated categories. The sex breakdown of the survey respondents was similar to that of the contact registry as a whole, but several participants were able to identify as nonbinary with the updated categories. Discussion: The updated categories allow researchers to provide a more inclusive race and ethnicity identification experience to participants. This may have implications for understanding differences in study populations that may translate to treatment response and has an overall aim to increase enrollment and adherence to observational research.

Indexed as

data collectiondemographicspopulation

Identifiers

PMID40757058
PMCPMC12317269

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.